Back to Search
Start Over
2022-RA-634-ESGO Trabectedin plus pegylated liposomaldoxorubicin in patients who experienced disease progression after PARPi maintenance: a real life case-control study
- Source :
- Ovarian cancer.
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group Ltd, 2022.
Details
- Database :
- OpenAIRE
- Journal :
- Ovarian cancer
- Accession number :
- edsair.doi...........934e703ddbe3eca63e3d9422f44eb29d
- Full Text :
- https://doi.org/10.1136/ijgc-2022-esgo.530